Post Marketing Surveillance to Monitor the Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Oral Live Attenuated Human Rotavirus Vaccine, Rotarix When Administered According to the Prescribing Information to Indian Infants.
Phase of Trial: Phase IV
Latest Information Update: 04 Jan 2018
At a glance
- Drugs RIX 4414 (Primary)
- Indications Rotavirus infections
- Focus Adverse reactions
- Acronyms ROTA-071 PMS
- Sponsors GlaxoSmithKline
- 15 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 31 Aug 2010 Status changed from completed to active, no longer recruiting as reported by Clinical Trials Registry - India.
- 04 May 2010 Actual end date (April 2010) added as reported by ClinicalTrials.gov.